Fig. 3From: Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levelsComparison of complete remission rate between rituximab and cyclophosphamide groups in IMN patientsCR, complete remissionBack to article page